Evolving the Potential of Cell and Gene Therapies via Engineering and Collaboration

Our team has spent more than a decade working to overcome the challenges of processing personalized cell and gene therapies (CGTs) locally, so that we can impact the lives of patients globally.

Orgenesis is paving the way to drastically lower costs for higher quality, standardized CGTs, regardless of patient location.

Unlocking the Potential of Cell and Gene Therapy for All

Personalized cell and gene therapies (CGTs) offer potential to address the world’s most challenging diseases. We are committed to helping to bring these advanced therapies to market effectively.

Unlocking the Potential of Cell and Gene Therapy for All

Personalized cell and gene therapies (CGTs) offer potential to address the world’s most challenging diseases. We are committed to helping to bring these advanced therapies to market effectively.

Unlocking the Potential of Cell and Gene Therapy for All

Personalized cell and gene therapies (CGTs) offer potential to address the world’s most challenging diseases. We are committed to helping to bring these advanced therapies to market effectively.

Bringing Advanced Therapies Within Reach

Providing advanced therapies to the patients who need them is complex and expensive. The Orgenesis POCare Platform was designed to simplify this process with a unique approach to drug development and scale-up.

Our team has forged relationships within the biotech industry and with top academia, research institutes and hospitals to commercialize point of care therapies across the globe.

A Global Platform

Our POCare Platform was designed to provide a harmonized pathway to commercialize advanced therapies.

Three primary components of the POCare Platform work in parallel to make these advances possible.

Learn More
Therapies
Technologies
Network